A successful clinical trial depends on accurate, high-quality data. However, missing data can significantly compromise all areas of the research, from key inferences made to regulatory compliance. Regulatory bodies have provided relatively little guidance on how to deal with the setbacks caused by missing data. Currently, many studies compensate by means of statistical analysis techniques. While this is a legitimate practice, it is usually not a comprehensive solution, and needs to be used in conjunction with other techniques.
The Missing Data in Clinical Trials Forum is the leading event to help you learn the most cutting-edge strategies to mitigate the effects of missing data in your clinical trials. The mission of this event is to explore the best practices and recent developments not only in adjusting data sets with missing data, but minimizing instances of missing data points in the first place, an area of great interest as the current trend of increasing clinical trial length and complexity continues.
This conference is designed for professionals in the pharmaceutical, medical device or biotechnology industries involved with the following:
This event is also of interest to: